Factors associated with potential drug-drug interactions in psychiatric inpatients
European Journal of Hospital Pharmacy
by Rankovic, A., Milentijevic, I., Jankovic, S.
1M ago
Objective The aim of this study was to investigate the prevalence and severity of potential drug–drug interactions (pDDIs) in hospitalised patients with major psychiatric disorders and to identify factors associated with their occurrence. Methods The research was designed as an observational, cross-sectional study conducted at the Clinic for Mental Disorders (CMD) ‘Dr. Laza Lazarevic’, Belgrade, Serbia. Medscape, Epocrates and Lexicomp bases were used to detect potential drug interactions among inpatients. Multivariate regression analysis was used to reveal risk and protective factors associat ..read more
Visit website
Correspondence on 'Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series
European Journal of Hospital Pharmacy
by Zhou, X. X., Ji, H. J.
1M ago
..read more
Visit website
Real-world effectiveness and durability of dual antiretroviral therapy in HIV-infected patients
European Journal of Hospital Pharmacy
by Perez-Cordon, L., Sanchez, A., Marin, S., Force, L., Serra-Prat, M., Palomera, E., Campins, L.
1M ago
Background and objectives While randomised controlled trials in HIV-infected patients have shown that certain dual antiretroviral therapy (DAT) regimens are non-inferior in terms of efficacy compared with classical triple-drug regimens, few real clinical experiences have been described. The aim of the study was to investigate, in real clinical practice, DAT effectiveness, durability, and risk factors for treatment discontinuation. Methods This was a prospective cohort study that included HIV-infected patients treated with DAT (2015–2020). DAT was considered effective when patients achieved or ..read more
Visit website
Interprofessional collaborative practice is strong in young health professionals: evidence from an Italian Winter School attended by hospital pharmacists and internal medicine physicians
European Journal of Hospital Pharmacy
by Camuffo, L., Mengato, D., Nobili, A., Santalucia, P., Proietti, M., Venturini, F.
1M ago
..read more
Visit website
Clinical trials
European Journal of Hospital Pharmacy
by Polidori, P., Makridaki, D., Kohl, S., delegates of the 52nd EAHP General Assembly
1M ago
..read more
Visit website
Rare case report of moxifloxacin-induced persistent hiccups
European Journal of Hospital Pharmacy
by Zhou, J., Wang, F., Li, S.
1M ago
Moxifloxacin is a broad-spectrum antimicrobial agent that is commonly used in clinical practice. Here we report an unusual case of a patient with persistent hiccups caused by moxifloxacin. A man aged in his 40s was treated with moxifloxacin for tuberculous pleurisy. Hiccups occurred 2 hours after intravenous injection of moxifloxacin and lasted into evening. On the second day after injection, hiccups occurred again and made it difficult for him to fall asleep. The clinician ruled out gastrointestinal disease, nervous system disease, electrolyte disturbance and other factors. On assessing causa ..read more
Visit website
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years
European Journal of Hospital Pharmacy
by Romagnoli, A., Santoleri, F., Costantini, A., Di Risio, A.
1M ago
Introduction Adherence to and persistence with long-term treatment with oral anticoagulants play a significant role in preventing adverse events and mortality in patients with cardiac conditions. The aim of this study was to evaluate the adherence, persistence and switching rate at 3 years in real-life patients with non-valvular atrial fibrillation receiving treatment with first-line new oral anticoagulants. Methods The study assessed all patients treated with drugs with the ATC codes B01AA, B01AE, B01AF and dispensed in pharmacies in the Lanciano-Vasto-Chieti and Pescara Local Health Units fr ..read more
Visit website
Off-label use of cardiovascular drugs as an indicator of therapeutic need in paediatrics
European Journal of Hospital Pharmacy
by Cammarata, S. M., Capone, G.
1M ago
..read more
Visit website
Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use
European Journal of Hospital Pharmacy
by Visscher, R., Yalcın, N., Bayraktar, I., Bayraktar-Ekincioglu, A.
1M ago
..read more
Visit website
Determination of plasma uracil as a screening for dihydropyrimidine dehydrogenase deficiency: clinical application in oncological treatments
European Journal of Hospital Pharmacy
by Tejedor-Tejada, E., Rubio Calvo, D., Garcia Andreo, A.
1M ago
Aims Treatment with dihydropyrimidines poses a significant risk of serious adverse reactions for patients with dihydropyrimidine dehydrogenase (DPD) deficiency. This study seeks to analyse the correlation between DPD deficiency and plasmatic uracil values in patients who are candidates for a fluoropyrimidine scheme. It also studies the incidence of adverse events (AEs) in patients with DPD deficiency established with plasmatic uracil determination. Methods This was a retrospective observational study conducted in a tertiary level establishment from September 2020 to April 2021. Patients includ ..read more
Visit website

Follow European Journal of Hospital Pharmacy on FeedSpot

Continue with Google
Continue with Apple
OR